These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2413795)

  • 1. Branch retinal artery occlusion after excessive use of nasal spray.
    Magargal LE; Sanborn GE; Donoso LA; Gonder JR
    Ann Ophthalmol; 1985 Aug; 17(8):500-1. PubMed ID: 2413795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thunderclap headache and reversible segmental cerebral vasoconstriction associated with use of oxymetazoline nasal spray.
    Loewen AH; Hudon ME; Hill MD
    CMAJ; 2004 Sep; 171(6):593-4. PubMed ID: 15367461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxymetazoline nasal spray three times daily for four weeks in normal subjects is not associated with rebound congestion or tachyphylaxis.
    Watanabe H; Foo TH; Djazaeri B; Duncombe P; Mackay IS; Durham SR
    Rhinology; 2003 Sep; 41(3):167-74. PubMed ID: 14579657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The "nose drop nose" due to oxymetazoline (Afrin) and other topical vasoconstrictors.
    Feinberg AR; Feinberg SM
    IMJ Ill Med J; 1971 Jul; 140(1):50-2. PubMed ID: 4104967
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-term use of oxy- and xylometazoline nasal sprays induces rebound swelling, tolerance, and nasal hyperreactivity.
    Graf P
    Rhinology; 1996 Mar; 34(1):9-13. PubMed ID: 8739860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute coronary syndrome after nasal spray of oxymetazoline.
    Montastruc F; Montastruc G; Taudou MJ; Olivier-Abbal P; Montastruc JL; Bondon-Guitton E
    Chest; 2014 Dec; 146(6):e214-e215. PubMed ID: 25451367
    [No Abstract]   [Full Text] [Related]  

  • 7. Fetal heart rate changes following maternal administration of a nasal decongestant.
    Baxi LV; Gindoff PR; Pregenzer GJ; Parras MK
    Am J Obstet Gynecol; 1985 Dec; 153(7):799-800. PubMed ID: 2416220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Tolerance and effectiveness of oxymetazoline and xylometazoline in treatment of acute rhinitis].
    Dorn M; Hofmann W; Knick E
    HNO; 2003 Oct; 51(10):794-9. PubMed ID: 14523532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Nasal decongestants and eye drops: keep out of children's reach!].
    Poulin-Chartrand S
    Perspect Infirm; 2013; 10(2):63. PubMed ID: 23539872
    [No Abstract]   [Full Text] [Related]  

  • 10. Sustained use of xylometazoline nasal spray shortens the decongestive response and induces rebound swelling.
    Graf P; Juto JE
    Rhinology; 1995 Mar; 33(1):14-7. PubMed ID: 7540314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bradycardia, hypotension, and near-syncope associated with Afrin (oxymetazoline) nasal spray.
    Glazener F; Blake K; Gradman M
    N Engl J Med; 1983 Sep; 309(12):731. PubMed ID: 6888446
    [No Abstract]   [Full Text] [Related]  

  • 12. [The observation of the ciliotoxicity of nasal mucosa with nasal decongestant].
    Teng Y; Zhang X; Xu G; Cai Q; Xu J
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 Sep; 19(18):824-6. PubMed ID: 16375111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Which nasal spray is preferred by patients?].
    Månsson I; Fredriksson H
    Lakartidningen; 1991 Feb; 88(6):406. PubMed ID: 1705641
    [No Abstract]   [Full Text] [Related]  

  • 14. ["Of snakes and crocodiles": central side effects of nose drops and facts about rhinitis medicamentosa].
    Bielenberg J
    Kinderkrankenschwester; 2011 Oct; 30(10):406-8. PubMed ID: 22029138
    [No Abstract]   [Full Text] [Related]  

  • 15. Non-ST-elevation myocardial infarction with the use of oxymetazoline nasal spray.
    Rajpal S; Morris LA; Akkus NI
    Rev Port Cardiol; 2014 Jan; 33(1):51.e1-4. PubMed ID: 24405558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extended use of topical nasal decongestants.
    Yoo JK; Seikaly H; Calhoun KH
    Laryngoscope; 1997 Jan; 107(1):40-3. PubMed ID: 9001263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anterior segment necrosis following treatment of central retinal artery occlusion: a clinicopathologic case report.
    Weidaw CD; Marcus DF; Reeser FH
    Ann Ophthalmol; 1978 Feb; 10(2):199-204. PubMed ID: 637487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are nasal decongestants safer than rhinitis? A case of oxymetazoline-induced syncope.
    Fabi M; Formigari R; Picchio FM
    Cardiol Young; 2009 Dec; 19(6):633-4. PubMed ID: 19775485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nasal airway resistance after decongestion with a nasal spray or a bellows device.
    Jessen M; Ivarsson A; Malm L
    Rhinology; 1996 Mar; 34(1):28-31. PubMed ID: 8739865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study of the effect of nasal steroid sprays in perennial allergic rhinitis patients with rhinitis medicamentosa.
    Ferguson BJ; Paramaesvaran S; Rubinstein E
    Otolaryngol Head Neck Surg; 2001 Sep; 125(3):253-60. PubMed ID: 11555762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.